Atractylodes macrocephala.   Bái zhú   White Atractylodes   Family: Asteraceae 
Macrocephala originates from macro = big; cephala = head; so, big-headed atractylodes.
Atractylodes refers mainly to Bai zhu. Less frequently used is Atractylodes lancea- Cang zhu. There are less-desirable and somewhat weaker substitutes, such as A. chinensis, A. japonicum, and A. ovata.[3]
PART USED: Rhizome
Nature- warm     FLAVOR: Sweet, bitter.
FUNCTIONS
GROUP: Replenishing Qi
1. Strengthen Spleen, dry up Dampness.
INDICATIONS
1. Poor appetite, abdominal swelling, diarrhea, sputum.
2. Vertigo, edema, fetus motion.
PATENT COMBINATIONS
COMPARISONS: Bai zhu and Cang zhu- both are Atractylodes and fortify the Spleen and dry Dampness.[4]
Bai zhu- slightly acrid, bitter but not very stong. Works to tonify and strengthen Spleen.[3]
Cang zhu- flavor more acrid- more into muscles, more for drying moisture, not very tonifying.[3]  However, Cang zhu is aromatic, bitter, and warm and has a dry and harsh nature. It upbears yang, dissipates depression, and dries dampness. It has a stronger upbearing and dissipating action than baizhu, but its ability to fortify the spleen, supplement qi, and engender blood is weaker.[4]
PREPARATIONS: Rhizome 4-9 g.[1]
Liquid extract 45% alcohol.[2]



References
Inner Path can not take any responsibility for any adverse effects from the use of plants. Always seek advice from a professional before using a plant medicinally.

Constituents

Research

Protective effects of Atractylodes macrocephala polysaccharide on liver ischemia-reperfusion injury and its possible mechanism in rats.
Jin C, Zhang PJ, Bao CQ, Gu YL, Xu BH, Li CW, Li JP, Bo P, Liu XN.
Abstract
Atractylodes macrocephala polysaccharide (AMP), a traditional Chinese medicine, is thought to have protective effects against liver injury. Therefore, this study was designed to explore the effects of AMP on hepatic ischemia-reperfusion injury (IRI) and elucidate the possible mechanisms. Ninety-six Sprague-Dawley rats were randomly divided into four groups with 24 rats per group: a normal control group, an IRI group, an AMP-treated group (0.4 g/kg/d) and a bifendate-treated group (100 mg/kg). Rats were treated with AMP or bifendate once daily for seven days by gastric gavage. The normal control group and the IRI model group received an equivalent volume of physiological saline. At 1, 6 and 24 h after surgery, the rats were killed and liver tissue samples were obtained to determine interleukin-1 (IL-1) expression by Western blotting and nuclear factor-κB (NF-κB) expression by immunohistochemistry. Liver morphology was assessed by microscopy and transmission electron microscopy. Blood samples were obtained to measure liver function (alanine aminotransferase, aspartate aminotransferase, total bilirubin and direct bilirubin). AMP significantly reduced the elevated expression of markers of liver dysfunction and the hepatic morphologic changes induced by hepatic IRI in rats. AMP also markedly inhibited IRI-induced lipid peroxidation and altered the activities of the antioxidant enzyme superoxide dismutase and malondialdehyde levels. Moreover, pretreatment with AMP suppressed the expression of interleukin-1β and NF-kB in IRI-treated rats. These results suggest that AMP exerts protective and therapeutic effects against hepatic IRI in rats, which might be associated with its antioxidant properties and inhibition of NF-κB activation. More studies are needed to better understand the mechanisms underlying the protective effects of AMP on hepatic IRI.
Am J Chin Med. 2011;39(3):489-502. ncbi.nlm.nih.gov


Atractylodes macrocephala Koidz stimulates intestinal epithelial cell migration through a polyamine dependent mechanism.
Song HP, Li RL, Zhou C, Cai X, Huang HY.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE:
Atractylodes macrocephala Koidz (AMK), a valuable traditional Chinese herbal medicine, has been widely used in clinical practice for treating patients with disorders of the digestive system. AMK has shown noteworthy promoting effect on improving gastrointestinal function and immunity, which might represent a promising candidate for the treatment of intestinal mucosa injury. The aim of this study was to investigate the efficacy of AMK on intestinal mucosal restitution and the underlying mechanisms via intestinal epithelial (IEC-6) cell migration model.
MATERIALS AND METHODS:
A cell migration model of IEC-6 cells was induced by a single-edge razor blade along the diameter of the cell layers in six-well polystyrene plates. After wounding, the cells were grown in control cultures and in cultures containing spermidine (5μM, SPD, reference drug), alpha-difluoromethylornithine (2.5mM, DFMO, polyamine inhibitor), AMK (50, 100, and 200mg/L), DFMO plus SPD and DFMO plus AMK for 12h. The polyamines content was detected by high-performance liquid chromatography (HPLC) with pre-column derivatization. The Rho mRNAs expression levels were assessed by Q-RT-PCR. The Rho and non-muscle myosin II proteins expression levels were analyzed by Western blot. The formation and distribution of non-muscle myosin II stress fibers were monitored with immunostaining techniques using specific antibodies and observed by confocal microscopy. Cell migration assay was carried out using inverted microscope and the Image-Pro Plus software. All of these indexes were used to evaluate the effectiveness of AMK.
RESULTS:
(1) Treatment with AMK caused significant increases in cellular polyamines content and Rho mRNAs and proteins expression levels, as compared to control group. Furthermore, AMK exposure increased non-muscle myosin II protein expression levels and formation of non-muscle myosin II stress fibers, and resulted in an acceleration of cell migration in IEC-6 cells. (2) Depletion of cellular polyamines by DFMO resulted in a decrease of cellular polyamines levels, Rho mRNAs and proteins expression, non-muscle myosin II protein formation and distribution, thereby inhibiting IEC-6 cell migration. AMK not only reversed the inhibitory effects of DFMO on the polyamines content, Rho mRNAs and proteins expression, non-muscle myosin II protein formation and distribution, but also restored cell migration to control levels.
CONCLUSIONS:
The results obtained from this study revealed that AMK significantly stimulates the migration of IEC-6 cells through a polyamine dependent mechanism, which could accelerate the healing of intestinal injury. These findings suggest the potential value of AMK in curing intestinal diseases characterized by injury and ineffective repair of the intestinal mucosa in clinical practice.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
J Ethnopharmacol. 2015 Jan 15;159:23-35. doi: 10.1016/j.jep.2014.10.059. Epub 2014 Nov 12. ncbi.nlm.nih.gov